Stock QLIFE QLIFE HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Qlife Holding AB Stock

Equities

QLIFE

SE0013486552

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-07-04 pm EDT 		5-day change 1st Jan Change
0.0013 SEK +18.18% Intraday chart for Qlife Holding AB -13.33% -93.47%
Jul. 02 Qlife Participates Research Trial for People Living with PKU and Gets Positive Data CI
Jun. 03 Qlife Starts Clinical Trial in China with First Biomarker on Egoo Health CI

Financials

Sales 2022 17.99M 1.71M Sales 2023 244K 23.25K Capitalization 12.84M 1.22M
Net income 2022 -93M -8.86M Net income 2023 -160M -15.25M EV / Sales 2022 4.67 x
Net Debt 2022 37.89M 3.61M Net Debt 2023 18.58M 1.77M EV / Sales 2023 129 x
P/E ratio 2022
-0.37 x
P/E ratio 2023
-0.05 x
Employees 11
Yield 2022 *
-
Yield 2023
-
Free-Float 94.85%
More Fundamentals * Assessed data

Chart Qlife Holding AB

Dynamic Chart

Latest news about Qlife Holding AB

Qlife Participates Research Trial for People Living with PKU and Gets Positive Data CI
Qlife Starts Clinical Trial in China with First Biomarker on Egoo Health CI
Qlife Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Qlife Places Danish Operational Company in Reconstruction Mode MT
Sweden's Qlife to Launch Biomarker Testing Platform in South Korea Via Potential Partnership MT
Qlife Signs Letter of Intent with Precision Biosensor CI
Qlife Secures Core Patent for Egoo System in EU, UK Markets MT
Qlife Announces its Core Patent for Egoo System Grants in EU and Other Countries in European Market, as Well as in United Kingdom CI
Qlife Holding AB Announces Update on Collaboration with Hipro Biotechnology CI
Qlife Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Qlife Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Qlife Holding AB Postpones the Publication of the Year-End Report for the Financial Year 2023 Until 8 February 2024 CI
Qlife Enters Collaboration Agreement with Hipro Biotechnology CI
Qlife, Hipro Biotechnology Ink Collaboration Deal for Egoo Health; Shares Soar MT
Qlife Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
More news

Press releases Qlife Holding AB

Qlife participates research trial for people living with PKU and gets positive data AQ
Qlife Holding AB publishes 2023 annual report AQ
Qlife starts clinical trial in China with first biomarker on Egoo Health AQ
QLIFE HOLDING AB, Interim Report Q1, January to March 2024 AQ
Qlife Holding AB enters into an addendum with the holders of the company's convertible debentures and all outstanding convertible debentures are converted into shares AQ
More press releases

Quotes and Performance

1 day+18.18%
1 week-13.33%
Current month+8.33%
1 month-40.91%
3 months-87.85%
6 months-92.93%
Current year-93.47%
More quotes

Highs and lows

1 week
0.00
Extreme 0.0009
0.00
1 month
0.00
Extreme 0.0009
0.00
Current year
0.00
Extreme 0.0009
0.02
1 year
0.00
Extreme 0.0009
0.09
3 years
0.00
Extreme 0.0009
50.80
5 years
0.00
Extreme 0.0009
60.00
10 years
0.00
Extreme 0.0009
60.00
More quotes

Managers and Directors - Qlife Holding AB

Managers TitleAgeSince
Peter Warthoe FOU
 Founder 57 18-12-31
Thomas Warthoe FOU
 Founder 57 19-10-10
Peter Thorsen DFI
 Director of Finance/CFO 58 Oct. 31
Members of the board TitleAgeSince
Thomas Warthoe FOU
 Founder 57 19-10-10
Lars Bangsgaard FOU
 Founder 71 22-12-31
Lars Wegner BRD
 Director/Board Member 50 22-12-31
More insiders

Quotes

Date Price Change Volume
24-07-04 0.0013 +18.18% 197,001,400
24-07-03 0.0011 -8.33% 91,607,320
24-07-02 0.0012 +9.09% 619,151,100
24-07-01 0.0011 -8.33% 219,410,900
24-06-28 0.0012 -20.00% 229,396,800

Delayed Quote Nasdaq Stockholm, July 04, 2024 at 12:00 pm EDT

More quotes

Company Profile

Qlife Holding AB is a Sweden-based medical technology Company that manufactures the hardware and software platform Egoo.health (Egoo) with which patients can carry out various types of biomarker tests based on a small amount of blood. Egoo performs analyzes that correlate to over 99 percent with high-performance laboratory instruments. The Egoo instrument measures biomarkers for the chronic diseases Phenylketonuria (PKU), rheumatoid arthritis (RA) and cancer. Qlife Holding is the parent company of the wholly owned Danish medical technology subsidiary Qlife ApS. Qlife ApS develops a medical technology product with the long-term goal of giving people access to safe and valid biomarker data at home.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-08-14 - Q2 2024 Earnings Release
More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
QLIFE HOLDING AB Stock Qlife Holding AB
-93.47% 384K
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.03% 178B
MEDTRONIC PLC Stock Medtronic plc
-6.32% 98.95B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-6.15% 66.14B
DEXCOM, INC. Stock DexCom, Inc.
-10.62% 44.11B
CENCORA, INC. Stock Cencora, Inc.
+8.34% 43.82B
HOYA CORPORATION Stock Hoya Corporation
+10.70% 42.07B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+11.64% 28.92B
TERUMO CORPORATION Stock Terumo Corporation
+18.71% 24.69B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-8.87% 23.38B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. QLIFE Stock